Detalhe da pesquisa
1.
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Blood
; 139(15): 2306-2315, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167655
2.
Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel.
Am J Kidney Dis
; 77(6): 990-992, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098925
3.
Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories.
Cytometry B Clin Cytom
; 100(6): 622-631, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915021
4.
Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy.
Leukemia
; 34(11): 3050-3054, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678290